Buy Hepion Pharmaceuticals Inc Stock | HEPA Stock Price & Latest News | Public
HEPA

Hepion Pharmaceuticals Inc

$0.00 (0.00%)Today
    Small Market Cap

    About HEPA

    Hepion Pharmaceuticals, Inc. engages in the development and commercialization of pleiotropic drug therapy for the treatment of chronic liver disease. It focuses on the development of its product candidate CRV431, a cyclophilin inhibitor that targets biochemical pathways...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.32
    -0.65
    -0.97
    Q1 2020
    Q2 2020
    Q3 2020
    Q4 2020

    Expected EPS
    Q4 2020

    -$0.40

    Actual EPS
    Q4 2020

    Stats

    Market Cap$28,06M
    Volume2,74k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$8.35
    1 Year Low$1.00
    Open$3.04
    High$3.04
    Low$3.00

    Buy any stock with any amount of money.

    Download the App
    Download the app